Nervous System Diseases
184
44
50
84
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
27 trials with published results (15%)
Research Maturity
84 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.6%
14 terminated out of 184 trials
85.7%
-0.8% vs benchmark
13%
24 trials in Phase 3/4
32%
27 of 84 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 84 completed trials
Clinical Trials (184)
Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin
Functional Near-infrared Spectroscopy in Unconscious Patients
Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)
Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
Collection of Biological Samples From Patients With Rare Neurological Diseases
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
Hypersensitivity to Amylin in Post-Traumatic Headache
Effects of the COTID (Community Occupational Therapist in Dementia) Program and Usual Occupational Therapy Care on Recurrence of Falls at 12 Months in Elderly People With Neurocognitive Disorders Who Had Been Hospitalized for Falls, After Their Return Home
Amylin-Induced Migraine Attacks Without Aura